OGEN: Oragenics Company Short-Term Debt

Symbol and logo of brand Oragenics (OGEN)

Oragenics, Inc. (OGEN) vaccine development is independent of economic cycles or GDP, demonstrating high resilience to crises. Unique patents in intranasal agents against viral brain lesions protect the company from price wars. The share price retrospective with the 0.00 indicator is presented below. The business relies on the creation of innovative drug delivery methods in US laboratories and a promising pipeline of new drugs.

OGEN (oragenics.com) Company Short-Term Debts history from 07/04/2022 to 10/31/2026

Metric breakdowns and analytics for Oragenics Inc. (OGEN)

- current quotes and average value forecast:
Price Chart Oragenics|OGEN - Fair Value Consensus
- market capitalization information:
Market Value Oragenics, Inc.|OGEN - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value per Share Oragenics|OGEN - Book Capitalization|Market Cap to Net Assets Ratio oragenics.com|OGEN - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Oragenics, Inc.|OGEN - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Oragenics, Inc.|OGEN - Company Aggregate Debt|Debts to Book Capitalization Oragenics, Inc.|OGEN - Long-Term Liabilities|Company Short-Term Debts Oragenics|Quick Ratio oragenics.com
- net income and valuation multiples indicators:
OGEN - Net Income
Fundamental valuation:Oragenics (OGEN)
Manufactured products of Oragenics, Inc.

Identifying fundamentally resilient assets requires a liquidity analysis based on the sum of all liabilities and notes payable maturing within one year. Current borrowings amounting to 0.00 measure the ability of Oragenics, Inc. (OGEN) to service its debt, which is critical given the binary risks of a biotech pipeline and the company's total dependence on external financing for survival, as reflected in this chart.

Key competitors

SMMT - Company Short-Term Debt|Company Short-Term Loans and Borrowings MRNA (Moderna Inc)|Vaxcyte Corp (PCVX) - Company Short-Term Debt|Company Current Liabilities Tarsus Corp|CRMD (CorMedix Inc.) - Company Short-Term Debts|Company Short-Term Debts serestherapeutics.com|Company Current Liabilities SPRO (Spero Therapeutics, Inc.)|SCYX (scynexis.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ANTX (AN2 Therapeutics)|Short-Term Debt Volume PolyPid Ltd (PYPD)|LSB - Company Short-Term Debt|ITRM (Iterum Therapeutics plc) - Company Short-Term Indebtedness|PHGE: Company Short-Term Debts|Current Liabilities SNGX (Soligenix)|SXTP (60 Degrees Pharmaceuticals Inc.) - Company Short-Term Debts|Short-Term Debt Onconetix Corporation ONCO|Company Short-Term Debts OPGN